Sensius Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 9

Sensius General Information

Description

Developer of oncology thermotherapy systems designed for adjunct cancer treatment purposes. The company's platform includes targeted heating of deep-seated tumors, microwave-based energy delivery, temperature control and treatment planning capabilities, integration with radiotherapy workflows, focused heat application technology, clinical research support, and thermotherapy treatment systems intended for use alongside radiotherapy, chemotherapy, and immunotherapy, enabling healthcare providers and oncology centers to apply localized heat treatment while supporting tumor-focused therapy and preservation of surrounding tissues.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit Ba 483A - Erasmus MC
  • Post Office Box 2040
  • 3000 CA Rotterdam
  • Netherlands
+31 010
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Outcome Management (Healthcare)
Vertical(s)
Corporate Office
  • Unit Ba 483A - Erasmus MC
  • Post Office Box 2040
  • 3000 CA Rotterdam
  • Netherlands
+31 010

Sensius Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sensius Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Secondary Transaction - Private 27-May-2026 Completed Product Development
13. Later Stage VC (Series A) 26-May-2025 Completed Product Development
12. Angel (individual) 12-Jun-2023 Completed Clinical Trials - Phase 1
11. Later Stage VC 29-Dec-2023 Completed Clinical Trials - Phase 1
10. Later Stage VC 25-Jan-2023 Completed Pre-Clinical Trials
9. Grant 16-Jun-2021 Completed Pre-Clinical Trials
8. Angel (individual) 08-Jun-2021 Completed Pre-Clinical Trials
7. Angel (individual) 13-May-2020 Completed Pre-Clinical Trials
6. Grant 09-May-2019 $56.1K $585K Completed Pre-Clinical Trials
5. Early Stage VC 13-Jan-2019 $171K $585K Completed Pre-Clinical Trials
To view Sensius’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Sensius Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of oncology thermotherapy systems designed for adjunct cancer treatment purposes. The company's platform inclu
Therapeutic Devices
Rotterdam, Netherlands
30 As of 2026

Rome, Italy

Velletri, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sensius Competitors (2)

One of Sensius’s 2 competitors is Medlogix (Italy), a Corporation company based in Rome, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medlogix (Italy) Corporation Rome, Italy
Andromedic Corporation Velletri, Italy
You’re viewing 2 of 2 competitors. Get the full list »

Sensius Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sensius Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
GrayBella Capital Venture Capital Minority
UCEA Capital Partners Family Office Minority
European Innovation Council Accelerator/Incubator Minority
Coöperatieve Rabobank Investment Bank Minority
EBAN (Brussels) Angel Group
You’re viewing 5 of 9 investors. Get the full list »

Sensius Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Sensius Uk London, United Kingdom 2020

Sensius FAQs

  • When was Sensius founded?

    Sensius was founded in 2015.

  • Where is Sensius headquartered?

    Sensius is headquartered in Rotterdam, Netherlands.

  • What is the size of Sensius?

    Sensius has 30 total employees.

  • What industry is Sensius in?

    Sensius’s primary industry is Therapeutic Devices.

  • Is Sensius a private or public company?

    Sensius is a Private company.

  • What is Sensius’s current revenue?

    The current revenue for Sensius is .

  • How much funding has Sensius raised over time?

    Sensius has raised $21.5M.

  • Who are Sensius’s investors?

    GrayBella Capital, UCEA Capital Partners, European Innovation Council, Coöperatieve Rabobank, and EBAN (Brussels) are 5 of 9 investors who have invested in Sensius.

  • Who are Sensius’s competitors?

    Medlogix (Italy) and Andromedic are competitors of Sensius.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process